Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

Abstract

The outcome of the first pilot study of liver-directed gene therapy is reported here. Five patients with homozygous familial hypercholesterolaemia (FH) ranging in age from 7 to 41 years were enrolled; each patient tolerated the procedure well without significant complications. Transgene expression was detected in a limited number of hepatocytes of liver tissue harvested four months after gene transfer from all five patients. Significant and prolonged reductions in low density lipoprotein (LDL) cholesterol were demonstrated in three of five patients; in vivo LDL catabolism was increased 53% following gene therapy in a receptor negative patient, who realized a reduction in serum LDL equal to 150 mg dl−1. This study demonstrates the feasibility of engrafting limited numbers of retrovirus-transduced hepatocytes without morbidity and achieving persistent gene expression lasting at least four months after gene therapy. The variable metabolic responses observed following low-level genetic reconstitution in the five patients studied precludes a broader application of liver-directed gene therapy without modifications that consistently effect substantially greater gene transfer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Brown, M.S. & Goldstein, J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34–37 (1986).

    Article  CAS  Google Scholar 

  2. Goldstein, J.L. & Brown, M.S. Familial hypercholesterolemia. Lipoprotein and lipid metabolism disorders. In Metabolic Basis of Inherited Disease, 6th edn (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 1215–1250 (McGraw-Hill, New York, 1989).

    Google Scholar 

  3. Uauy, R., Vega, G.L., Grundy, S.M. & Bilheimer, D.M. Lovastatin therapy in receptor-negative familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover. J. Pediatr. 113, 387–392 (1988).

    Article  CAS  Google Scholar 

  4. Malloy, M.J., Kane, J.P., Kunitake, S.T. & Tun, P. Complimentarity of colestipol, niacin and lovastatin in treatment of severe familial hypercholesterolemia. Ann. intern. Med. 107, 616–623 (1987).

    Article  CAS  Google Scholar 

  5. Starzl, T.E. et al. Portacaval shunt in patients with familial hypercholesterolemia. Ann. Surg. 198, 273–283 (1983).

    Article  CAS  Google Scholar 

  6. Deckelbaum, R.J., Lees, R.S., Small, D.M., Hedberg, S.E. & Grundy, S.M. Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia. New Engl. J. Med. 296, 465–470 (1977).

    Article  CAS  Google Scholar 

  7. Bilheimer, D.W., Goldstein, J.L., Grundy, S.M. & Starzl, T.E. Liver transplantation to provide low density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. New Engl. J. Med. 311, 1658–1664 (1984).

    Article  CAS  Google Scholar 

  8. Hoeg, J.M., Starzl, T.E. & Brewer, H.B. Liver transplantation for treatment of cardiovascular disease: Comparison with medication and plasma exchange in homozygous familial hypercholesterolemia. Am. J. Cardiol. 59, 705–707 (1987).

    Article  CAS  Google Scholar 

  9. Thompson, G.R., Barbir, M., Okabayshi, K., Trayner, I. & Larkin, S. Plasmapheresis in familial hypercholesterolemia. Arteriosclerosis (Suppl.) 9, 1152–1157 (1989).

    Google Scholar 

  10. Gordon, B.R. et al. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate Cellulose adsorption system. Am. J. Cardiol. 70, 1010–1016 (1992).

    Article  CAS  Google Scholar 

  11. Goldstein, J.L., Kita, T. & Brown, M.S. Defective lipoprotein receptors and atherosclerosis. New Engl. J. Med. 309, 288–296 (1983).

    Article  CAS  Google Scholar 

  12. Ishibashi, S. et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. clin. Invest. 92, 883–893 (1993).

    Article  CAS  Google Scholar 

  13. Chowdhury, J.R. et al. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 254, 1802–1805 (1991).

    Article  CAS  Google Scholar 

  14. Grossman, M., Wilson, J.M. & Raper, S.E. A novel approach for Introducing hepatocytes into the portal circulation. J. Lab. clin. Med. 121, 472–478 (1993).

    CAS  PubMed  Google Scholar 

  15. Grossman, M., Raper, S.E. & Wilson, J.M. Transplantation of genetically-modified autologous hepatocytes into non-human primates: Feasibility and short-term toxicity. Hum. Gene Ther. 3, 501–510 (1992).

    Article  CAS  Google Scholar 

  16. Wilson, J.M. et al. Clinical protocol: Ex vivo gene therapy of familial hypercholesterolemia. Hum. Gene Ther. 3, 179–222 (1992).

    Article  CAS  Google Scholar 

  17. Grossman, M. et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nature Genet. 6, 335–341 (1994).

    Article  CAS  Google Scholar 

  18. Raper, S.E. et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann. Surg. (in the press).

  19. Rader, D.J. et al. The LDL receptor is not required for normal catabolism of Lp (a) in humans. J. clin. Invest. 95, 1403–1408 (1995).

    Article  CAS  Google Scholar 

  20. Grossman, G., Raper, S.E. & Wilson, J.M. Towards liver-directed gene therapy: Retrovirus-mediated gene transfer into human hepatocytes. Somatic Cell molec. Genet. 17, 601–607 (1991).

    Article  CAS  Google Scholar 

  21. Adams, R.M. et al. Transduction of primary human hepatocytes with amphotropic and xenotropic retroviral vectors. Proc. natn. Acad. Sci. U.S.A. 89, 8981–8985 (1992).

    Article  CAS  Google Scholar 

  22. Brown, M.S., Goldstein, J.L., Havel, R.J. & Steinberg, D. Gene therapy for cholesterol. Nature Genet. 7, 349–350 (1994).

    Article  CAS  Google Scholar 

  23. Ishibashi, S. et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. clin. Invest. 92, 883–893 (1993).

    Article  CAS  Google Scholar 

  24. Kozarsky, K.F. et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. biol. Chem. 269, 13695–13702 (1994).

    CAS  PubMed  Google Scholar 

  25. Hobbs, H., Brown, M.S. & Goldstein, J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mut. 1, 445–466 (1992).

    Article  CAS  Google Scholar 

  26. Leitersdorf, E., Tobin, E.J., Davignon, J. & Hobbs, H.H. Common low-density lipoprotein receptor mutations in the French Canadian population. J. clin. Invest. 85, 1014–1023 (1990).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grossman, M., Rader, D., Muller, D. et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1, 1148–1154 (1995). https://doi.org/10.1038/nm1195-1148

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1195-1148

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing